Colombo Stock Exchange closed lower: ASPI fell 0.28% (down 56.48 pts) to 19,927.30 and the S&P SL20 fell 0.43% to 5,656.91. Market turnover was LKR 1.5 billion; top gainers included Distilleries, PGP Glass, Singer and Asiri, while Carson Cumberbatch, Bukit Darah, JKH, Hayleys and Commercial Bank led decliners.
Healthcare · Hospital/Nursing Management
Ceylon Hospitals PLC (Durdans) is a Sri Lanka-based private healthcare group that provides hospital-based care and an expanding network of diagnostic and laboratory services.
CHL shares are down 7.6% over the past year and last closed at Rs 64.90 on Nov 17, 2026.
Fundamentals
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | Rs 11.0B +12.6% | Rs 9.8B +6.5% | Rs 9.2B +15.8% | Rs 7.9B +0.8% | Rs 7.8B +41.4% | Rs 5.5B -7.2% | Rs 6.0B +2.9% | Rs 5.8B +1.3% |
| Operating profit | Rs 1.6B +34.5% | Rs 1.2B +64.6% | Rs 703.9M -25.2% | Rs 941.0M -30.9% | Rs 1.4B +112.8% | Rs 639.8M -0.7% | Rs 644.6M +3.5% | Rs 622.9M -5.5% |
| Net profit | Rs 1.1B +44.9% | Rs 726.0M +60.0% | Rs 453.8M -30.4% | Rs 651.7M -41.3% | Rs 1.1B +84.8% | Rs 600.3M +28.5% | Rs 467.1M +24.1% | Rs 376.3M -22.9% |
| EPS | 5.68 -65.3% | 16.38 +41.3% | 11.59 -31.3% | 16.88 -41.8% | 29.00 +75.3% | 16.54 +38.9% | 11.91 +25.4% | 9.50 -20.0% |
Compared with the same period a year earlier.
Per-share figures are as reported, not adjusted for splits.
Dividend history
All 10 dividends and ex-dates →| Ex-date | Dividend | Per share | Payment date |
|---|---|---|---|
| Jun 1, 2026 | FY2026 · first interim | Rs 1.10 | Jun 18, 2026 |
| Jun 23, 2025 | FY2025 · first interim | Rs 4.00 | Jul 11, 2025 |
| Jun 11, 2024 | FY2024 · first interim | Rs 2.00 | Jul 2, 2024 |
| May 22, 2023 | FY2023 · first interim | Rs 2.30 | Jun 9, 2023 |
| May 30, 2022 | FY2022 · first interim | Rs 5.00 | Jun 20, 2022 |
| May 28, 2021 | FY2021 · first interim | Rs 3.20 | Jun 14, 2021 |
| Aug 28, 2020 | FY2020 · first and final | Rs 2.20 | Sep 17, 2020 |
| May 21, 2019 | FY2019 · second interim | Rs 3.60 | May 30, 2019 |
Upcoming dividends, rights issues and splits across the CSE: dividend calendar →
| # | Company | Mkt cap | P/E | P/B | EPS | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| 1 | ASIR.N0000 | Rs 35.3B | 6.1 | 1.31 | 5.07 | 11.69% | 0.00% |
| 2 | LHCL.N0000 | Rs 23.8B | 12.2 | 1.40 | 8.69 | 15.17% | 2.82% |
| 3 | NHL.N0000 | Rs 16.8B | 15.9 | 2.46 | 0.75 | 16.28% | 0.00% |
| 4 | CHL.N0000 · this company | Rs 10.4B | 11.4 | 0.88 | 5.68 | 8.71% | 1.69% |
| 5 | SINH.N0000 | Rs 9.9B | 41.0 | 7.78 | 0.56 | 4.65% | 0.00% |
| 6 | AMSL.N0000 | Rs 6.8B | 7.0 | 0.83 | 1.84 | 11.97% | 0.00% |
| Peer median · 5 companies | - | 12.2 | 1.40 | - | - | 0.00% |
About Ceylon Hospitals Plc
Ceylon Hospitals PLC (Durdans) is a Sri Lanka-based private healthcare group that provides hospital-based care and an expanding network of diagnostic and laboratory services. The Group's narrative focuses on delivering inpatient, outpatient and day-case care alongside specialised clinical services supported by surgical and diagnostic capabilities. Operations include the main Durdans hospital and an islandwide laboratory and diagnostics network, complemented by education and workforce development through the Amrak Institute of Medical Sciences and related subsidiaries. Named subsidiaries in the Group scope include Durdans Medical & Surgical Hospital (Pvt) Ltd, Amrak Institute of Medical Sciences (Pvt) Ltd and Ceygen Biotech (Pvt) Ltd. The Group operates across Sri Lanka with its head office in Colombo and has expanded services into regions including Galle and Kurunegala, maintaining standards aligned with international accreditation and pursuing digital and service expansion initiatives.
AI analysis
bullishEvidence points bullish: September profit grew 44.1% as operating margin widened, reinforcing a moderately undervalued starting point. The catch is that the share is more expensive than its own history on both P/E and P/B.
Read the full report (Nov 13, 2026) →News sentiment
Describes news flow, not a forecast1 article in 30 days: 0 positive, 0 negative, 1 neutral.
Dialog Axiata reduced its combined stake in Digital Health from 64.66% to 44.66%, selling 16.65% (3,747,132 shares) to Sunshine Healthcare for LKR 312.17m and 3.35% (752,868 shares) to Nawaloka for LKR 62.72m; Digital Health will be reclassified from a subsidiary to an associate. Sunshine now holds 21.92%; Nawaloka 12.12%; Asiri 13.33%.
Sunshine Holdings' unit Sunshine Healthcare bought a 21.92% stake in Digital Health (Doc990) for LKR 410.83 million via two share purchase agreements on Oct 16, acquiring 16.65% from Dialog Axiata's subsidiary and 5.26% from Ceylon Hospitals.
Colombo bourse opened flat with the ASPI down 0.06% at 20,173.56 and market turnover Rs 232.69m (banks led turnover Rs 108.38m). Sunshine Holdings' unit bought ~21.92% of Digital Health for Rs 410.83m; Union Chemicals declared a Rs48 interim dividend (record date Oct 28, pay Nov 13, 2026).
Dialog Axiata sold part of its stake in Digital Health (Doc990), reducing the Dialog Group's holding to 44.66% and causing Digital Health to cease being a Group subsidiary. Sunshine Healthcare paid to become a c.21.92% holder (total outlay Rs.410.8m) while Nawaloka raised its stake to 12.12% and Durdans exited; price was Rs.83.31/share valuing Digital Health at Rs.1.87bn.
Dividend · Rs 1.10 · XD Jun 1, 2026
First Interim dividend of LKR 1.1/share; XD 2026-06-01; record 2026-06-01; payable 2026-06-18; FY 31st March 2026
Share split · 1:4 · XD Mar 5, 2026
Colombo bourse closed the week up 3.45% as the ASPI rose 0.54% yesterday to 23,654.30, with the market gaining about Rs. 264.8 billion in value for the week and daily turnover over Rs. 8.5 billion; top contributors included JKH, COMB, VONE, CARS and NTB.
Ceylon Hospitals (Durdans) will seek shareholder approval to subdivide voting shares from 31,762,723 to 127,050,892 and non-voting shares from 10,133,765 to 40,535,060 (1-for-4); stated capital will remain at 1,778,802,331.50 rupees and the plan is pending regulatory approval.
Ceylon Hospitals (Durdens) will propose a 4-for-1 subdivision of both ordinary voting and non-voting shares, subject to regulatory and shareholder approvals. Voting shares would rise to 127,050,892 and non-voting to 40,535,060, with stated capital unchanged at Rs. 1,778,802,331.50.
Healthcare sector: what is happening
Last 30 days to Nov 18, 2026Healthcare news centred on public-sector purchasing, with procurement reforms and PROMIS digital monitoring intended to speed medicine purchases, affecting suppliers' order flow and delivery cycles. Cabinet approval to draft amendments to the Ayurveda Act would formalise regulation of indigenous medicine and enable licences for local-medicine exports. ADB-backed social-protection investment also includes eldercare, supporting care-service capacity.
The stories behind it
Auto-generated from 11 sector news articles over 30 days. Not investment advice.